Open-label Milnacipran for Persistent Knee Pain One Year After Total Knee Arthroplasty (TKA)

Summary

The current study examines the effects of milnacipran in patients who have chronic persistent knee pain one year or longer after total knee arthroplasty (TKA) to evaluate for a pain-relieving effect.

Timeline

Start

2010-10

Primary completion

2011-07

Completion

2011-07

Publications

• Results Marks DM, Bolognesi MP. Open-label milnacipran for patients with persistent knee pain 1 year or longer after total knee arthroplasty: a pilot study. Prim Care Companion CNS Disord. 2013;15(4):PCC.12m01496. doi: 10.4088/PCC.12m01496. Epub 2013 Jul 11.

Drugs

Indications